Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effects of Ketamine in the Acute Phase of Suicidal Ideation: a Multicenter Randomized Double-blind Trial

NCT02299440 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.

NCT NCT02299440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02299440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effects of Ketamine in the Acute Phase of Suicidal Ideation: a Multicenter Randomized Double-blind Trial
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2015
Completion date
November 21, 2019
Enrollment
156 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

suicidal ideation